MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

A new research report from a New York based co. Emerging Market...

  1. 259 Posts.
    A new research report from a New York based co. Emerging Market Equity Research dated July 1st released today can be read at www.metabolic.com.au under the broker reseach section. They have a 12 month price target of $1.97.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.